Exploring Data Quality Management within Clinical Trials

被引:28
|
作者
Houston, Lauren [1 ,2 ]
Probst, Yasmine [1 ,2 ]
Yu, Ping [3 ]
Martin, Allison [1 ,2 ]
机构
[1] Univ Wollongong, Fac Sci Med & Hlth, Sch Med, 228-41 Northfields Ave, Wollongong, NSW 2522, Australia
[2] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia
[3] Univ Wollongong, Sch Comp & Informat Technol, Fac Engn & Informat Sci, Wollongong, NSW, Australia
来源
APPLIED CLINICAL INFORMATICS | 2018年 / 9卷 / 01期
关键词
data quality; data management; clinical trial; clinical research; public health; SOURCE DATA VERIFICATION; SITE; FRAMEWORK; SYSTEMS;
D O I
10.1055/s-0037-1621702
中图分类号
R-058 [];
学科分类号
摘要
Background Clinical trials are an important research method for improving medical knowledge and patient care. Multiple international and national guidelines stipulate the need for data quality and assurance. Many strategies and interventions are developed to reduce error in trials, including standard operating procedures, personnel training, data monitoring, and design of case report forms. However, guidelines are nonspecific in the nature and extent of necessary methods. Objective This article gathers information about current data quality tools and procedures used within Australian clinical trial sites, with the aim to develop standard data quality monitoring procedures to ensure data integrity. Methods Relevant information about data quality management methods and procedures, error levels, data monitoring, staff training, and development were collected. Staff members from 142 clinical trials listed on the National Health and Medical Research Council (NHMRC) clinical trials Web site were invited to complete a short self-reported semiquantitative anonymous online survey. Results Twenty (14%) clinical trials completed the survey. Results from the survey indicate that procedures to ensure data quality varies among clinical trial sites. Centralized monitoring (65%) was the most common procedure to ensure high-quality data. Ten (50%) trials reported having a data management plan in place and two sites utilized an error acceptance level to minimize discrepancy, set at < 5% and 5 to 10%, respectively. The quantity of data variables checked (10-100%), the frequency of visits (once-a-month to annually), and types of variables (100%, critical data or critical and noncritical data audits) for data monitoring varied among respondents. The average time spent on staff training per person was 11.58 hours over a 12-month period and the type of training was diverse. Conclusion Clinical trial sites are implementing ad hoc methods pragmatically to ensure data quality. Findings highlight the necessity for further research into "standard practice" focusing on developing and implementing publicly available data quality monitoring procedures.
引用
收藏
页码:72 / 81
页数:10
相关论文
共 50 条
  • [31] Standardization in the data management of clinical trials based on MedDRA
    Marschner, M
    [J]. PHARMAZEUTISCHE INDUSTRIE, 2004, 66 (5A): : 619 - 622
  • [32] The role of quality of life data as an endpoint for collecting real-world evidence within geroscience clinical trials
    Harinath, Girish
    Zalzala, Sajad
    Nyquist, Andy
    Wouters, Maartje
    Isman, Anar
    Moel, Mauricio
    Verdin, Eric
    Kaeberlein, Matt
    Kennedy, Brian
    Bischof, Evelyne
    [J]. AGEING RESEARCH REVIEWS, 2024, 97
  • [33] Learning from OCTET – exploring the acceptability of clinical trials management methods
    Catherine Arundel
    Judith Gellatly
    [J]. Trials, 19
  • [34] Learning from the OCTET trial - exploring acceptability of clinical trials management
    Arundel, Catherine
    Gellatly, Judith L.
    [J]. TRIALS, 2017, 18
  • [35] Learning from OCTET - exploring the acceptability of clinical trials management methods
    Arundel, Catherine
    Gellatly, Judith
    [J]. TRIALS, 2018, 19
  • [36] Improving data quality within an environmental management system
    Riebel, PN
    [J]. PULP & PAPER-CANADA, 1999, 100 (06) : 64 - +
  • [37] COMPUTER-AIDED DATA MANAGEMENT AND DATA QUALITY-CONTROL IN MULTI-CENTER CLINICAL CANCER TRIALS
    VANGLABBEKE, M
    BUYSE, M
    RENARD, J
    DEPAUW, M
    [J]. CONTROLLED CLINICAL TRIALS, 1981, 2 (01): : 87 - 87
  • [38] EXPLORING THE APPLICATION OF QUALITY MANAGEMENT PRINCIPLES WITHIN A MILITARY TRAINING UNIT
    Els, R. C.
    Meyer, H. W.
    Heystek, J.
    [J]. JOURNAL FOR NEW GENERATION SCIENCES, 2022, 20 (02) : 25 - 39
  • [39] How a Data-Driven Quality Management System Can Manage Compliance Risk in Clinical Trials
    Djali, Sina
    Janssens, Stef
    Van Yper, Stefan
    Van Parijs, Jan
    [J]. DRUG INFORMATION JOURNAL, 2010, 44 (04): : 359 - 373
  • [40] How a Data-Driven Quality Management System Can Manage Compliance Risk in Clinical Trials
    Sina Djali
    Stef Janssens
    Stefan Van Yper
    Jan Van Parijs
    [J]. Drug information journal : DIJ / Drug Information Association, 2010, 44 (4): : 359 - 373